The Jackson Laboratory
Lead PartnerThe Jackson Laboratory is a leading provider of cancer mouse models and in vivo oncology services and a National Cancer Institute-designated Cancer Center. Drawing on decades of research experience we provide capabilities around model selection, husbandry and customizable oncology studies to help clients and researchers evaluate novel anti-cancer therapies. Our diverse oncology study protocols range from traditional xenograft services to PDX cancer models and advanced humanized mouse models for immuno-oncology drug development.
Crown Bioscience Inc.
Crown Bioscience is a global drug discovery and development solutions company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, CrownBio enables clients to deliver superior clinical candidates and accelerate drug development programs. CrownBio also provides preclinical immunotherapy research platforms supporting the successful transition of immunotherapeutics from the lab into the clinic.
Champions Oncology was founded by renowned specialists in the field of cancer diagnosis, treatment, and research. The Champions Oncology team is comprised of seasoned oncology professionals passionately dedicated to working to accelerate oncology drug development, improve treatment outcomes and extend lives. Champions Personalized TumorGrafts™ empower patients and physicians using an in vivo xenograft mouse avatar-based diagnostic model that has shown to be predictive of a patients’ clinical response.
MI Bioresearch (MI), a preclinical oncology service provider, offers in vitro services, oncology pharmacology, in vivo imaging, and focal radiation to support research programs. Our team explores the effects of your drugs and biologics using both human and syngeneic models and multi-modality imaging systems. MI provides you with decision-driving data to help advance your drug candidate toward the next cancer research breakthrough. One Focus. One Purpose. Oncology Research.
Hera Biolabs, Inc., is an innovative pre-clinical contract research organization [CRO] utilizing cutting-edge gene-editing technologies to create novel in vivo models for oncology. Given our mission to accelerate cancer research and drug development, we focus upon rat models to deliver translationally-relevant, high-quality results. Using proprietary technologies, Hera built the SRGTM Platform, a double knockout Sprague-Dawley rat engineered for T-cell, B-cell, and NK cell deficiency. Our first SRG model is the OncoRat®, uniquely suited for xenograft studies given its excellent tumor take-rates and ability to deliver masses 10x that of mouse models in half the time – all without the increased risk of genetic drift from multiple passages as observed in mice.
Pharmatest Services Ltd is a CRO offering preclinical efficacy services for the pharmaceutical industry. We offer bothin vitro and in vivo models in the fields of oncology and skeletal diseases. In oncology we have special expertise in clinically predictive orthotopic and metastasis models, and especially models of bone metastasis
Studylog’s Animal Study Workflow Software® is designed for biomedical animal research and provides features for the design, planning, execution, analysis, and reporting of animal studies in a standardized, highly efficient manner, while protecting data integrity. Reducing many labs’ study-related labor by half, Studylog automates and streamlines the entire animal study process, making it easier, faster and cheaper, so researchers have more time and resources to get their job done.
Repositive is a technology company with the mission to increase discovery, access and sharing of genomic data for the benefit of patients. In 2017 we initiated a collaboration with leading biopharma organisations and CROs to launch the Cancer Models Platform to act as a market place of translational oncology models and a network for oncology researchers. The platform incorporates PDX, CDX, syngeneic and humanised mouse models, 3D in vitro systems and other popular translational cancer models. Our vision is becoming the largest catalogue of commercially available oncology models.